Aker BioMarine Signs New Strategic Partnership in Southeast Asia 

Aker BioMarine is excited to announce the official signing of a distribution agreement with Brenntag Specialties, the global market leader in chemicals and ingredients distribution. The new distribution agreement covers health supplements such as Superba 2, Superba 2 Halal, Superba Boost, and Antarctic Krill Oil for the complementary medicine segment and underscores Aker BioMarine’s commitment to providing high-quality, sustainable krill oil products to customers in Southeast Asia.

“This new strategic partnership with Brenntag Specialties is significant in our efforts to serve the nutraceutical segment in Southeast Asia by offering innovative solutions backed by scientific research,” said Ross Norris, General Manager Asia Pacific, Aker BioMarine. “Brenntag’s extensive network and expertise will help bring our products to a broader audience, while making a positive impact on the health and vitality of consumers across Southeast Asia.”

“We are delighted to enter this strategic partnership with Aker BioMarine who sets sustainability and health at the heart of their values. Aker BioMarine solutions are innovative, clinically proven, and have multiple health benefits and we will use all our expertise and capabilities to bring these complementary solutions to our customers and consumers across Southeast Asia. This agreement reinforces Brenntag Specialties’ complementary medicines offering in Southeast Asia and affirms our focus on pharmaceutical and nutraceutical solutions across the APAC region,” said Romain Girard, Regional President, Pharma Asia Pacific, Brenntag Specialties.

About Aker BioMarine:

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including Understory™, Aker BioMarine’s new high-quality single source protein brand, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. FloraMarine™, the highest, natural concentration of DHA on the market, is the newest ingredient in the Aker BioMarine portfolio. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. Read more: www.akerbiomarine.com

About Brenntag:

Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,700 employees worldwide and operates a network of about 600 sites in 72 countries. In 2023, Brenntag generated sales of 16.8 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 50 ESG and DAX ESG Target. For more information, visit www.brenntag.com.

For more information, please contact:

Lisa Miller

Communications Director


+1 (281) 914-1304